DUBLIN--(BUSINESS WIRE)--The "Muscular Dystrophy - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.
This latest pipeline guide provides comprehensive information on the therapeutics under development for Muscular Dystrophy (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The pipeline guide also reviews of key players involved in therapeutic development for Muscular Dystrophy and features dormant and discontinued projects.
The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 5, 2, 1, 29 and 14 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 2 and 6 molecules, respectively.
Companies Mentioned
- Acceleron Pharma Inc
- Achelios Therapeutics Inc
- AMO Pharma Ltd
- Benitec Biopharma Ltd
- Bio Blast Pharma Ltd
- Biophytis SA
- Corcept Therapeutics Inc
- Evotec AG
- Fulcrum Therapeutics Inc
- Genethon SA
- Gilead Sciences Inc
- Marina Biotech Inc
- Pfizer Inc
- Prothelia Inc
- Recursion Pharmaceuticals Inc
- Resverlogix Corp
- SanBio Inc
- Santhera Pharmaceuticals Holding AG
- Sarepta Therapeutics Inc
- Strykagen Corp
- Ultragenyx Pharmaceutical Inc
Key Topics Covered
- Introduction
- Muscular Dystrophy - Overview
- Muscular Dystrophy - Therapeutics Development
- Muscular Dystrophy - Therapeutics Assessment
- Muscular Dystrophy - Companies Involved in Therapeutics Development
- Muscular Dystrophy - Drug Profiles
- Muscular Dystrophy - Dormant Projects
- Muscular Dystrophy - Discontinued Products
- Muscular Dystrophy - Product Development Milestones
- Appendix
For more information about this report visit https://www.researchandmarkets.com/research/644jkk/muscular?w=4
